Literature DB >> 20855738

Effect of N-1/c-8 ring fusion and C-7 ring structure on fluoroquinolone lethality.

Muhammad Malik1, Kevin R Marks, Heidi A Schwanz, Nadezhda German, Karl Drlica, Robert J Kerns.   

Abstract

Quinolones rapidly kill bacteria by two mechanisms, one that requires protein synthesis and one that does not. The latter, which is measured as lethal action in the presence of the protein synthesis inhibitor chloramphenicol, is enhanced by N-1 cyclopropyl and C-8 methoxy substituents, as seen with the highly lethal compound PD161144. In some compounds, such as levofloxacin, the N-1 and C-8 substituents are fused. To assess the effect of ring fusion on killing, structural derivatives of levofloxacin and PD161144 differing at C-7 were synthesized and examined with Escherichia coli. A fused-ring derivative of PD161144 exhibited a striking absence of lethal activity in the presence of chloramphenicol. In general, ring fusion had little effect on lethal activity when protein synthesis was allowed, but fusion reduced lethal activity in the absence of protein synthesis to extents that depended on the C-7 ring structure. Additional fused-ring fluoroquinolones, pazufloxacin, marbofloxacin, and rufloxacin, also exhibited reduced activity in the presence of chloramphenicol. Energy minimization modeling revealed that steric interactions of the trans-oriented N-1 cyclopropyl and C-8 methoxy moieties skew the quinolone core, rigidly orient these groups perpendicular to core rings, and restrict the rotational freedom of C-7 rings. These features were not observed with fused-ring derivatives. Remarkably, structural effects on quinolone lethality were not explained by the recently described X-ray crystal structures of fluoroquinolone-topoisomerase IV-DNA complexes, suggesting the existence of an additional drug-binding state.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20855738      PMCID: PMC2981251          DOI: 10.1128/AAC.01054-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

1.  Killing of Staphylococcus aureus by C-8-methoxy fluoroquinolones.

Authors:  X Zhao; J Y Wang; C Xu; Y Dong; J Zhou; J Domagala; K Drlica
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

2.  The bactericidal activity of DR-3355, an optically active isomer of ofloxacin.

Authors:  C S Lewin; S G Amyes
Journal:  J Med Microbiol       Date:  1989-11       Impact factor: 2.472

3.  Lethality of quinolones against Mycobacterium smegmatis in the presence or absence of chloramphenicol.

Authors:  Muhammad Malik; Tao Lu; Xilin Zhao; Anubha Singh; Christopher M Hattan; John Domagala; Robert Kerns; Karl Drlica
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

4.  Norfloxacin-induced DNA gyrase cleavage complexes block Escherichia coli replication forks, causing double-stranded breaks in vivo.

Authors:  Jennifer Reineke Pohlhaus; Kenneth N Kreuzer
Journal:  Mol Microbiol       Date:  2005-06       Impact factor: 3.501

5.  The DNA gyrase-quinolone complex. ATP hydrolysis and the mechanism of DNA cleavage.

Authors:  S C Kampranis; A Maxwell
Journal:  J Biol Chem       Date:  1998-08-28       Impact factor: 5.157

6.  4-Quinolone bactericidal mechanisms.

Authors:  B M Howard; R J Pinney; J T Smith
Journal:  Arzneimittelforschung       Date:  1993-10

7.  MECHANISM OF ACTION OF NALIDIXIC ACID ON ESCHERICHIA COLI.II. INHIBITION OF DEOXYRIBONUCLEIC ACID SYNTHESIS.

Authors:  W A GOSS; W H DEITZ; T M COOK
Journal:  J Bacteriol       Date:  1965-04       Impact factor: 3.490

8.  Inhibition of RNA synthesis by oxolinic acid is unrelated to average DNA supercoiling.

Authors:  S H Manes; G J Pruss; K Drlica
Journal:  J Bacteriol       Date:  1983-07       Impact factor: 3.490

9.  DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage.

Authors:  C R Chen; M Malik; M Snyder; K Drlica
Journal:  J Mol Biol       Date:  1996-05-17       Impact factor: 5.469

10.  Improved bactericidal activity of Q-35 against quinolone-resistant staphylococci.

Authors:  T Ito; M Matsumoto; T Nishino
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

View more
  7 in total

1.  Bactericidal activity of ACH-702 against nondividing and biofilm Staphylococci.

Authors:  Steven D Podos; Jane A Thanassi; Melissa Leggio; Michael J Pucci
Journal:  Antimicrob Agents Chemother       Date:  2012-04-30       Impact factor: 5.191

2.  Fluoroquinolone and quinazolinedione activities against wild-type and gyrase mutant strains of Mycobacterium smegmatis.

Authors:  Muhammad Malik; Kevin R Marks; Arkady Mustaev; Xilin Zhao; Kalyan Chavda; Robert J Kerns; Karl Drlica
Journal:  Antimicrob Agents Chemother       Date:  2011-03-07       Impact factor: 5.191

3.  Crystal structure and stability of gyrase-fluoroquinolone cleaved complexes from Mycobacterium tuberculosis.

Authors:  Tim R Blower; Benjamin H Williamson; Robert J Kerns; James M Berger
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-20       Impact factor: 11.205

4.  Testing the mutant selection window hypothesis with Escherichia coli exposed to levofloxacin in a rabbit tissue cage infection model.

Authors:  W Ni; X Song; J Cui
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-14       Impact factor: 3.267

5.  Specific patterns of gyrA mutations determine the resistance difference to ciprofloxacin and levofloxacin in Klebsiella pneumoniae and Escherichia coli.

Authors:  Yingmei Fu; Wenli Zhang; Hong Wang; Song Zhao; Yang Chen; Fanfei Meng; Ying Zhang; Hui Xu; Xiaobei Chen; Fengmin Zhang
Journal:  BMC Infect Dis       Date:  2013-01-07       Impact factor: 3.090

6.  Suppression of gyrase-mediated resistance by C7 aryl fluoroquinolones.

Authors:  Muhammad Malik; Arkady Mustaev; Heidi A Schwanz; Gan Luan; Nirali Shah; Lisa M Oppegard; Ernane C de Souza; Hiroshi Hiasa; Xilin Zhao; Robert J Kerns; Karl Drlica
Journal:  Nucleic Acids Res       Date:  2016-03-16       Impact factor: 16.971

7.  Design and virtual screening of novel fluoroquinolone analogs as effective mutant DNA GyrA inhibitors against urinary tract infection-causing fluoroquinolone resistant Escherichia coli.

Authors:  Sakthivel Balasubramaniyan; Navabshan Irfan; Appavoo Umamaheswari; Ayarivan Puratchikody
Journal:  RSC Adv       Date:  2018-06-29       Impact factor: 4.036

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.